Influence of ABCB1 and CYP3A5 gene polymorphisms on pharmacokinetics of apixaban in patients with atrial fibrillation and acute stroke

Influence of ABCB1 and CYP3A5 gene polymorphisms on pharmacokinetics of apixaban in patients with atrial fibrillation and acute stroke

Alexander Valerevich Kryukov,1 Dmitry Alekseevich Sychev,1 Denis Anatolevich Andreev,2 Kristina Anatolievna Ryzhikova,1 Elena Anatolievna Grishina,1 Anastasia Vladislavovna Ryabova,1 Mark Alekseevich Loskutnikov,3 Valeriy Valerevich Smirnov,4 Olga Dmitrievna Konova,1 Irina Andreevna Matsneva,2 Pavel...

Full description

Bibliographic Details
Main Authors: Kryukov AV, Sychev DA, Andreev DA, Ryzhikova KA, Grishina EA, Ryabova AV, Loskutnikov MA, Smirnov VV, Konova OD, Matsneva IA, Bochkov PO
Format: Article
Language:English
Published: Dove Medical Press 2018-03-01
Series:Pharmacogenomics and Personalized Medicine
Subjects:
cardioembolic stroke
atrial fibrillation
non-vitamin K anticoagulants
apixaban
pharmacokinetics
pharmacogenetics
Online Access:https://www.dovepress.com/influence-of-abcb1-and-cyp3a5-gene-polymorphisms-on-pharmacokinetics-o-peer-reviewed-article-PGPM

Internet

https://www.dovepress.com/influence-of-abcb1-and-cyp3a5-gene-polymorphisms-on-pharmacokinetics-o-peer-reviewed-article-PGPM

Similar Items